WallStreetZenWallStreetZen

NASDAQ: KURA
Kura Oncology Inc Stock Ownership - Who owns Kura Oncology?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Kura Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Troy Edward WilsonPresident and CEO2026-03-236,103$6.15
$37.53kBuy
Thomas MalleyDirector2026-03-1810,000$3.12
$31.20kBuy
Teresa Brophy BairChief Legal Officer2026-01-272,335$8.46
$19.76kSell
Teresa Brophy BairChief Legal Officer2026-01-274,777$8.46
$40.42kSell
Kathleen FordChief Operating Officer2026-01-271,813$8.46
$15.34kSell
Teresa Brophy BairChief Legal Officer2026-01-274,096$8.46
$34.66kSell
Francis BurrowsChief Scientific Officer2026-01-271,311$8.46
$11.09kSell
Thomas James DoyleSVP Finance Accounting2026-01-272,226$8.46
$18.83kSell
Thomas James DoyleSVP Finance Accounting2026-01-271,114$8.46
$9.43kSell
Thomas James DoyleSVP Finance Accounting2026-01-27695$8.46
$5.88kSell

1 of 4

KURA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KURA insiders and whales buy or sell their stock.

KURA Shareholders

What type of owners hold Kura Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc10.20%9,010,793$83.98MInstitution
Bvf Inc9.76%8,617,162$80.31MInstitution
Suvretta Capital Management LLC9.71%8,575,422$79.92MInstitution
Vanguard Group Inc6.24%5,507,627$51.33MInstitution
Armistice Capital LLC5.59%4,936,000$46.00MInstitution
State Street Corp5.58%4,931,090$45.96MInstitution
Ecor1 Capital Fund Qualified LP4.99%4,408,097$41.08MInsider
Aqr Capital Management LLC3.47%3,062,212$28.54MInstitution
Prosight Management LP2.86%2,529,600$23.58MInstitution
Geode Capital Management LLC2.30%2,028,618$18.91MInstitution

1 of 3

KURA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KURA90.17%9.83%Net SellingNet Buying
VOR52.26%26.07%Net SellingNet Selling
EVMN56.26%43.74%Net BuyingNet Buying
KZIA0.04%0.39%
ABUS30.49%69.51%
View Top Biotech Stocks

Kura Oncology Stock Ownership FAQ

Who owns Kura Oncology?

Kura Oncology (NASDAQ: KURA) is owned by 96.62% institutional shareholders, 10.53% Kura Oncology insiders, and 0.00% retail investors. Ecor1 Capital Fund Qualified LP is the largest individual Kura Oncology shareholder, owning 4.41M shares representing 4.99% of the company. Ecor1 Capital Fund Qualified LP's Kura Oncology shares are currently valued at $41.52M.

If you're new to stock investing, here's how to buy Kura Oncology stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.